DAVITA INC. (DVA) FY2026 Q2 P&L / Income Statement

Published Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)

Revenue by Business Segment by Health Care Revenue Source

Swipe to see the full flow
DAVITA INC. (DVA) FY2026 Q2 P&L / Income StatementIncome statement for 2026-04-01 through 2026-06-30. View: Segments by Health Care Organization, Revenue Sources. Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUEOPERATINGPRE-TAXNETU. S. Dialysis And Related Lab Services - Medicare and Medicare AdvantageU. S. Dialysis And Related Lab Services - Commercial PayorsU. S. Dialysis And Related Lab Services - Medicaid and Managed MedicaidUndisclosed (calculated)U. S. Dialysis And Related Lab Services - Other Government PayorsOther Operating Segment - Other Government PayorsOther Operating Segment - Commercial PayorsTotal revenuesOperating incomeTotal operating expensesPatient care costsGeneral and administrativeDepreciation and amortizationEquity investment income, netIncome before income taxesOther income (expense), net (calculated)Net incomeIncome tax expenseTotal revenuesTotal revenues$3.55 BOperating incomeOperating income$579.00 MIncome before income taxesPretax income$435.01 MNet incomeNet income$343.22 MU. S. Dialysis And Related Lab Services - Medicare and Medicare AdvantageU. S. Dialysis And RelatedLab Services - Medicareand Medicare Advantage$1.75 BTotal operating expensesTotal operatingexpenses$2.98 BIncome tax expenseIncome tax expense$91.79 MOther income (expense), net (calculated)Other income,net (calculated)−$143.99 MU. S. Dialysis And Related Lab Services - Commercial PayorsU. S. Dialysis And Related LabServices - Commercial Payors$940.23 MPatient care costsPatient care costs$2.39 BU. S. Dialysis And Related Lab Services - Medicaid and Managed MedicaidU. S. Dialysis And RelatedLab Services - Medicaidand Managed Medicaid$226.94 MGeneral and administrativeGeneral and administrative$423.46 MUndisclosed (calculated)Undisclosed (calculated)$176.35 MDepreciation and amortizationDepreciation and amortization$167.81 MU. S. Dialysis And Related Lab Services - Other Government PayorsU. S. Dialysis And Related LabServices - Other Government Payors$88.85 MEquity investment income, netEquity investment income, net−$8.18 MOther Operating Segment - Other Government PayorsOther Operating Segment -Other Government Payors$236.38 MOther Operating Segment - Commercial PayorsOther Operating Segment- Commercial Payors$136.05 M
Chart details

DAVITA INC. (DVA) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Segments by Health Care Organization, Revenue Sources. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues
3,554,084,000 US dollars
Total operating expenses
2,975,083,000 US dollars
Operating income
579,001,000 US dollars
Other income (expense), net (calculated)
negative 143,991,000 US dollars
Income before income taxes
435,010,000 US dollars
Income tax expense
91,787,000 US dollars
Net income
343,223,000 US dollars
U. S. Dialysis And Related Lab Services - Commercial Payors
940,228,000 US dollars
U. S. Dialysis And Related Lab Services - Medicaid and Managed Medicaid
226,944,000 US dollars
U. S. Dialysis And Related Lab Services - Medicare and Medicare Advantage
1,749,289,000 US dollars
U. S. Dialysis And Related Lab Services - Other Government Payors
88,848,000 US dollars
Other Operating Segment - Commercial Payors
136,052,000 US dollars
Other Operating Segment - Other Government Payors
236,377,000 US dollars
Undisclosed (calculated)
176,346,000 US dollars
Patient care costs
2,392,001,000 US dollars
Depreciation and amortization
167,808,000 US dollars
Equity investment income, net
negative 8,184,000 US dollars
General and administrative
423,458,000 US dollars

Chart connections

  • Revenue minus operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
  • Of which attributable to DAVITA INC.: $265.40 M; to noncontrolling interests: $77.83 M.
DAVITA INC. (DVA) FY2026 Q2 Revenue by Business Segment by Health Care Revenue Source Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!